| Basics |
iRhythm Technologies, Inc.
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
|
| IPO Date: |
October 20, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Instruments and Equipment |
| Market Cap: |
$5.72B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.30 | 2.25%
|
| Avg Daily Range (30 D): |
$2.41 | 1.37%
|
| Avg Daily Range (90 D): |
$2.38 | 1.47%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.35M |
| Avg Daily Volume (30 D): |
.26M |
| Avg Daily Volume (90 D): |
.32M |
| Trade Size |
| Avg Trade Size (Sh.): |
53 |
| Avg Trade Size (Sh.) (30 D): |
31 |
| Avg Trade Size (Sh.) (90 D): |
32 |
| Institutional Trades |
| Total Inst.Trades: |
4,436 |
| Avg Inst. Trade: |
$3.04M |
| Avg Inst. Trade (30 D): |
$7.99M |
| Avg Inst. Trade (90 D): |
$6.8M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.93M |
| Avg Closing Trade (30 D): |
$8.37M |
| Avg Closing Trade (90 D): |
$8.99M |
| Avg Closing Volume: |
36.9K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-2.93
|
$-.44
|
$-.97
|
|
Diluted EPS
|
$-2.93
|
$-.44
|
$-.97
|
|
Revenue
|
$ 657.23M
|
$ 186.69M
|
$ 158.68M
|
|
Gross Profit
|
$ 458.62M
|
$ 132.86M
|
$ 109.22M
|
|
Net Income / Loss
|
$ -92.43M
|
$ -14.22M
|
$ -30.7M
|
|
Operating Income / Loss
|
$ -105.65M
|
$ -18.71M
|
$ -32.56M
|
|
Cost of Revenue
|
$ 198.61M
|
$ 53.83M
|
$ 49.46M
|
|
Net Cash Flow
|
$ -241.43M
|
$ -66.16M
|
$ -44.3M
|
|
PE Ratio
|
|
|
|
|
|
|
